• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.11% Nasdaq Up 0.09%

    CEL-SCI Corporation (CVM)

    -NYSE MKT
    0.11 Down 0.07(36.48%) Dec 2, 4:02PM EST
    |After Hours : 0.11 Down 0.00 (1.67%) Dec 2, 4:13PM EST
    Prev Close:0.18
    Open:0.12
    Bid:0.11 x 100
    Ask:0.11 x 300
    1y Target Est:3.00
    Beta:-1.2559
    Next Earnings Date:N/A
    Day's Range:0.10 - 0.12
    52wk Range:0.10 - 0.66
    Volume:9,051,301
    Avg Vol (3m):897,744
    Market Cap:17.71M
    P/E (ttm):N/A
    EPS (ttm):-0.18
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CVM

    Comparison

    Symbol% ChgMkt Cap
    CVMDown 36.48%17.71M
    CLDXDown 0.56%359.43M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):221.94
    Ex-Dividend Date:28-Aug-96

    Analysts

    Annual EPS Est (Sep-15) :N/A
    Quarterly EPS Est (Sep-15) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback